Literature DB >> 18922095

"Gently rough": the vaccine potential of a Salmonella enterica regulatory lipopolysaccharide mutant.

Gábor Nagy1, Tamás Palkovics, Andreas Otto, Harald Kusch, Béla Kocsis, Ulrich Dobrindt, Susanne Engelmann, Michael Hecker, Levente Emödy, Tibor Pál, Jörg Hacker.   

Abstract

BACKGROUND: An alternative to multivalent vaccines could be to construct strains capable of conferring broad protection through shared antigens. Down-regulation of immunodominant major antigens has been proposed to enhance the immunogenicity of conserved antigens.
METHODS: The protection provided by an aroA as well as structural and regulatory lipopolysaccharide (LPS) mutants of Salmonella enterica serovar Typhimurium against homologous and heterologous challenges was assessed in the murine model of typhoid. The reactivity and cross-reactivity of the immune sera raised was tested by enzyme-linked immunospot assay and immunoblots. Conserved outer membrane proteins were identified by mass spectrometry.
RESULTS: Unlike any structural LPS mutants, the regulatory mutant lacking RfaH was finely balanced between safety and immunogenicity, and its vaccine potential was comparable to that of the well-characterized DeltaaroA mutant. Loss of the transcriptional antiterminator RfaH resulted in a heterogeneous length of LPS chains, designated here as the "gently rough" phenotype. Our study also provides evidence that the rough phenotype enhances the immunogenicity of minor antigens, which may improve cross-protection against heterologous bacteria. A panel of conserved antigens shared by members of the Enterobacteriaceae family was identified as abundant porins and lipoprotein antigens.
CONCLUSIONS: Fine-tuned down-regulation of immunodominant epitopes can create live vaccine strains that are not only desirably attenuated but that also exhibit an improved cross-protective potential.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18922095     DOI: 10.1086/593069

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

Review 1.  Genome dynamics and its impact on evolution of Escherichia coli.

Authors:  Ulrich Dobrindt; M Geddam Chowdary; G Krumbholz; J Hacker
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

2.  Regulated delayed expression of rfc enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.

Authors:  Qingke Kong; Qing Liu; Angela M Jansen; Roy Curtiss
Journal:  Vaccine       Date:  2010-07-03       Impact factor: 3.641

3.  Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.

Authors:  Qingke Kong; Jiseon Yang; Qing Liu; Praveen Alamuri; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

4.  Salmonella typhimurium-induced M1 macrophage polarization is dependent on the bacterial O antigen.

Authors:  Fengling Luo; Xiaoming Sun; Zhen Qu; Xiaolian Zhang
Journal:  World J Microbiol Biotechnol       Date:  2016-01-08       Impact factor: 3.312

5.  Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.

Authors:  Chun Huang; Qing Liu; Yali Luo; Pei Li; Qiong Liu; Qingke Kong
Journal:  Vaccine       Date:  2016-08-05       Impact factor: 3.641

6.  Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen.

Authors:  Qingke Kong; Qing Liu; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

7.  The extradomain a of fibronectin enhances the efficacy of lipopolysaccharide defective Salmonella bacterins as vaccines in mice.

Authors:  Beatriz San Román; Victoria Garrido; Pilar-María Muñoz; Laura Arribillaga; Begoña García; Ximena De Andrés; Virginia Zabaleta; Cristina Mansilla; Inmaculada Farrán; Iñigo Lasa; Damián De Andrés; Beatriz Amorena; Juan-José Lasarte; María-Jesús Grilló
Journal:  Vet Res       Date:  2012-04-19       Impact factor: 3.683

8.  Two Novel Salmonella Bivalent Vaccines Confer Dual Protection against Two Salmonella Serovars in Mice.

Authors:  Xinxin Zhao; Qinlong Dai; Renyong Jia; Dekang Zhu; Mafeng Liu; Mingshu Wang; Shun Chen; Kunfeng Sun; Qiao Yang; Ying Wu; Anchun Cheng
Journal:  Front Cell Infect Microbiol       Date:  2017-09-04       Impact factor: 5.293

9.  Safety, Protective Immunity, and DIVA Capability of a Rough Mutant Salmonella Pullorum Vaccine Candidate in Broilers.

Authors:  Rongxian Guo; Yang Jiao; Zhuoyang Li; Shanshan Zhu; Xiao Fei; Shizhong Geng; Zhiming Pan; Xiang Chen; Qiuchun Li; Xinan Jiao
Journal:  Front Microbiol       Date:  2017-04-05       Impact factor: 5.640

10.  An rfaH Mutant of Salmonella enterica Serovar Typhimurium is Attenuated in Swine and Reduces Intestinal Colonization, Fecal Shedding, and Disease Severity Due to Virulent Salmonella Typhimurium.

Authors:  Bradley L Bearson; Shawn M D Bearson; Jalusa D Kich; In Soo Lee
Journal:  Front Vet Sci       Date:  2014-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.